Corneal Outcomes of Scleral Lens Wear

Overview

About this study

Aims

1. Determine the corneal cellular changes that occur in response to scleral lens wear.

2. Determine the role of lens clearance over the cornea in relation to corneal cellular changes

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 years or older
  • Keratoconus or ocular surface disease requiring scleral lens wear

 

Exclusion Criteria:

  • Significant corneal scarring.
  • Co-existing corneal disease other than the primary diagnosis (above)
  • Systemic diseases or medications known to affect the cornea, e.g. diabetes, amiodarone
  • Glaucoma or ocular hypertension

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Cherie Nau, O.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions